Deutsche Bank’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.6K Sell
14,219
-2,071
-13% -$10.3K ﹤0.01% 3469
2026
Q2
$92.5K Buy
16,290
+1,010
+7% +$8.14K ﹤0.01% 3495
2026
Q1
$140K Buy
15,280
+1,469
+11% +$20.6K ﹤0.01% 3137
2025
Q4
$221K Buy
13,811
+352
+3% +$10.3K ﹤0.01% 2967
2025
Q3
$627K Buy
13,459
+1,595
+13% +$58.6K ﹤0.01% 2435
2025
Q2
$348K Buy
11,864
+2,398
+25% +$65.2K ﹤0.01% 2646
2025
Q1
$243K Sell
9,466
-257
-3% -$6.33K ﹤0.01% 2866
2024
Q4
$281K Buy
9,723
+4,370
+82% +$133K ﹤0.01% 2948
2024
Q3
$127K Buy
5,353
+60
+1% +$1.33K ﹤0.01% 3137
2024
Q2
$91.5K Buy
+5,293
New +$92.5K ﹤0.01% 3148
2022
Q2
– Sell
-2,363
Closed -$84K – 4354
2022
Q1
$84K Buy
2,363
+955
+68% +$59.7K ﹤0.01% 3640
2021
Q4
$123K Buy
1,408
+73
+5% +$6.05K ﹤0.01% 3616
2021
Q3
$153K Buy
+1,335
New +$198K ﹤0.01% 3702

Other funds holding LENZ

Deutsche Bank's LENZ Position: Q3 2026 in Review

Deutsche Bank reduced its LENZ Therapeutics (LENZ) stake by 13% in Q3 2026, selling an estimated $10.3K and leaving 14,219 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3469.

Deutsche Bank first reported a position in LENZ in Q3 2021 and has held it in 13 quarters since. The position peaked at $627K in Q3 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Deutsche Bank held 14,219 shares of LENZ Therapeutics worth $54.6K as of Q3 2026.
  • Deutsche Bank sold 2,071 LENZ Therapeutics shares in Q3 2026, an estimated $10.3K.
  • LENZ Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3469 holding.
  • Deutsche Bank first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 13 quarters since.
  • Deutsche Bank's LENZ Therapeutics position peaked at $627K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.